Spectral md awarded barda project bioshield contract valued at $149 million for ai-driven deepview® burn wound imaging technology

Dallas, sept. 28, 2023 (globe newswire) -- spectral md, inc. (“smd”), a subsidiary of spectral ai, inc. (nasdaq: mdai; mdaiw) (“spectral ai” or the “company”), an artificial intelligence (ai) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced it has been awarded a new contract valued at up to $149 million by the biomedical advanced research and development authority (barda), part of the administration for strategic preparedness and response (aspr) within the u.s. department of health and human services. the contract is for the advanced development of the deepview® system, the company's ai-driven burn wound imaging technology, to be used at emergency departments, trauma centers and burn centers, for both routine burn care and as a medical countermeasure for use in burn mass casualty incidents (bmci).
MDAI Ratings Summary
MDAI Quant Ranking